Uh oh. Looks like there is whole lot of truth here. Just the facts. No spin! For the three months ended June 30, 2016, total revenue decreased to approximately $0.79 million from $1.41 million, a 43.8% decrease over the same period of 2015. Revenues are generated primarily from three sources: new enrollment/processing fees; recurring storage fees (both from cord blood and cord tissue); and services related to the procurement of birth tissue for organizations utilized in the transplantation and/or research of therapeutic products. The decrease in revenue is due primarily to a reduction in orders for services related to procurement of birth tissue. Recurring storage revenues increased approximately 3.7% to $0.68 million for the three month period ended June 30, 2016, versus $0.66 million for the prior comparative year ended June 30, 2015. Revenues from the procurement of birth tissue decreased to $0.0 million for the three month period ended June 30, 2016 from $0.52 million for the three month period ended June 30, 2015.